Perampanel Patent Expiration
Perampanel is used for controlling seizures in patients with epilepsy. It was first introduced by Catalyst Pharmaceuticals Inc
Perampanel Patents
Given below is the list of patents protecting Perampanel, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Fycompa | US8772497 | Method for producing 1, 2-dihydropyridine-2-one compound | Jul 01, 2026 | Catalyst Pharms |
| Fycompa | US6949571 | 1,2-dihydropyridine compounds, process for preparation of the same and use thereof | May 23, 2025 | Catalyst Pharms |
Perampanel's Family Patents
Explore Our Curated Drug Screens
Perampanel Generic API Manufacturers
Several generic applications have been filed for Perampanel. The first generic version for Perampanel was by Teva Pharmaceuticals Usa Inc and was approved on Jun 8, 2021. And the latest generic version is by Accord Healthcare Inc and was approved on Jun 8, 2021.
Given below is the list of companies who have filed for Perampanel generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 6 different strengths of generic version for Perampanel. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | tablet | Prescription | ORAL | AB | Jun 8, 2021 |
| 4MG | tablet | Prescription | ORAL | AB | Jun 8, 2021 |
| 6MG | tablet | Prescription | ORAL | AB | Jun 8, 2021 |
| 8MG | tablet | Prescription | ORAL | AB | Jun 8, 2021 |
| 10MG | tablet | Prescription | ORAL | AB | Jun 8, 2021 |
| 12MG | tablet | Prescription | ORAL | AB | Jun 8, 2021 |
2. TEVA PHARMS USA INC
Teva Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Perampanel. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2MG | tablet | Prescription | ORAL | AB | Jun 8, 2021 |
| 4MG | tablet | Prescription | ORAL | AB | Jun 8, 2021 |
| 6MG | tablet | Prescription | ORAL | AB | Jun 8, 2021 |
| 8MG | tablet | Prescription | ORAL | AB | Jun 8, 2021 |
| 10MG | tablet | Prescription | ORAL | AB | Jun 8, 2021 |
| 12MG | tablet | Prescription | ORAL | AB | Jun 8, 2021 |